Smith Thomas B's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Sep 3, 2025
- Accession no.
- 0001062993-25-015277
- Filed
- Sep 3, 2025
- Trade date
- Aug 29, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $671.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Thomas BCIK 0001748462 | Officer (EVP and Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Common Stock | SSaleDisposed | −17,478 | $38.42 | −$671,504.76 | 70,264 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.